Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Peroxiredoxin like 2A pseudogene 1 (PRXL2AP1)** is a human pseudogene related by sequence homology to the peroxiredoxin-like 2A family, but is classified as a pseudogene, meaning it does not encode a functional protein. There is no evidence it acts as a receptor, enzyme, transporter, or classical therapeutic target. Pseudogenes can sometimes have regulatory functions at the RNA level, such as acting as miRNA decoys or influencing related gene expression, but no such functional association has been characterized for PRXL2AP1 specifically. The gene is annotated principally as a unit of genetic sequence without any confirmed biological or pathophysiological function[2][5][6]. **Notes:** - This gene is **not considered an actionable therapeutic target**. It is a pseudogene—not a protein-coding gene, receptor, enzyme, or other molecular target[2]. - There is no evidence that PRXL2AP1 contributes to any disease as a driver or biomarker, nor that any drugs interact with it or target it. - The entry is correct in name and general category, but it is "incorrect" as a molecular target in drug discovery or therapeutic context (not a receptor, not "druggable," not a driver of disease) and should be annotated accordingly. If you need information about the functional/coding gene, refer to PRXL2A (Peroxiredoxin like 2A, also known as FAM213A/Adiporedoxin)[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxiredoxin like 2A pseudogene 1 (PRXL2AP1).